v3.25.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Apr. 25, 2025
Apr. 26, 2024
Apr. 28, 2023
Income Statement [Abstract]      
Net sales $ 33,537 $ 32,364 $ 31,227
Costs and expenses:      
Cost of products sold, excluding amortization of intangible assets 11,632 11,216 10,719
Research and development expense 2,732 2,735 2,696
Selling, general, and administrative expense 10,849 10,736 10,415
Amortization of intangible assets 1,807 1,693 1,698
Restructuring charges, net 267 226 375
Certain litigation charges, net 317 149 (30)
Other operating (income) expense, net (23) 464 (131)
Operating profit 5,955 5,144 5,485
Other non-operating income, net (402) (412) (515)
Interest expense, net 729 719 636
Income before income taxes 5,628 4,837 5,364
Income tax provision 936 1,133 1,580
Net income 4,691 3,705 3,784
Net income attributable to noncontrolling interests (29) (28) (26)
Net income attributable to Medtronic $ 4,662 $ 3,676 $ 3,758
Basic earnings per share (in dollars per share) $ 3.63 $ 2.77 $ 2.83
Diluted earnings per share (in dollars per share) $ 3.61 $ 2.76 $ 2.82
Basic weighted average shares outstanding (in shares) 1,285.6 1,327.7 1,329.8
Diluted weighted average shares outstanding (in shares) 1,289.9 1,330.2 1,332.8